Coronaviruses

Figures & data

Figure 1. Remdesivir, the only small molecule drug approved for the treatment of SARS-CoV-2 infection

Figure 2. Structure of pritelivir, a helicase-primase primary sulfonamide inhibitor, also acting as an efficient carbonic anhydrase inhibitor [30,32,33]

Carta F, Birkmann A, Pfaff T, et al. Lead development of thiazolylsulfonamides with carbonic anhydrase inhibitory action. J Med Chem. 2017;60:3154–3164.

 PubMed Web of Science ®Google Scholar

Mishra CB, Tiwari M, Supuran CT. Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: where are we today? Med Res Rev. 2020;40:2485–2565.

 PubMed Web of Science ®Google Scholar

Nocentini A, Angeli A, Carta F, et al. Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. J Enzyme Inhib Med Chem. 2021;36:561–580.

 PubMed Web of Science ®Google Scholar